- Home
- FGL vs RLYB Comparison
FGL vs RLYB Comparison
Compare FGL & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGL
- RLYB
- Stock Information
- Founded
- FGL 2021
- RLYB 2018
- Country
- FGL Malaysia
- RLYB United States
- Employees
- FGL N/A
- RLYB N/A
- Industry
- FGL
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- FGL
- RLYB Health Care
- Exchange
- FGL NYSE
- RLYB Nasdaq
- Market Cap
- FGL 21.0M
- RLYB 25.0M
- IPO Year
- FGL 2024
- RLYB 2021
- Fundamental
- Price
- FGL $1.52
- RLYB $0.30
- Analyst Decision
- FGL
- RLYB Hold
- Analyst Count
- FGL 0
- RLYB 5
- Target Price
- FGL N/A
- RLYB $11.50
- AVG Volume (30 Days)
- FGL 73.4K
- RLYB 201.6K
- Earning Date
- FGL 12-17-2024
- RLYB 05-08-2025
- Dividend Yield
- FGL N/A
- RLYB N/A
- EPS Growth
- FGL 45.69
- RLYB N/A
- EPS
- FGL 0.04
- RLYB N/A
- Revenue
- FGL $23,268,519.00
- RLYB $636,000.00
- Revenue This Year
- FGL N/A
- RLYB N/A
- Revenue Next Year
- FGL N/A
- RLYB N/A
- P/E Ratio
- FGL $38.69
- RLYB N/A
- Revenue Growth
- FGL 336.06
- RLYB N/A
- 52 Week Low
- FGL $1.16
- RLYB $0.22
- 52 Week High
- FGL $5.26
- RLYB $2.00
- Technical
- Relative Strength Index (RSI)
- FGL N/A
- RLYB 31.16
- Support Level
- FGL N/A
- RLYB $0.24
- Resistance Level
- FGL N/A
- RLYB $0.28
- Average True Range (ATR)
- FGL 0.00
- RLYB 0.05
- MACD
- FGL 0.00
- RLYB 0.00
- Stochastic Oscillator
- FGL 0.00
- RLYB 18.31
About FGL FOUNDER GROUP LTD
Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.